Appointment booking for Dr. Sarika Shivnani, MD is currently not available.Dr. Sarika Shivnani, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Sarika Shivnani, MD (she/her) is an Endocrinologist in Plano, TX with over 16 years of experience. What is your opinion of Dr. Sarika Shivnani, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 16 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sarika Shivnani, MD has received over $2,661 which includes payments from the following companies:
$523.35 from Novo Nordisk Inc
$425.33 from AstraZeneca Pharmaceuticals LP
$265.59 from INSULET CORPORATION
$232.93 from Janssen Pharmaceuticals, Inc
$205.75 from Takeda Pharmaceuticals America, Inc.
$158.54 from sanofi-aventis U.S. LLC
$132.59 from Valeritas, Inc.
$110.06 from AbbVie, Inc.
$105.98 from LILLY USA, LLC
$100.00 from COMSORT, Inc
$79.89 from Shire North American Group Inc
$54.66 from Amgen Inc.
$51.40 from GlaxoSmithKline, LLC.
$43.15 from Boehringer Ingelheim Pharmaceuticals, Inc.
$25.59 from Salix Pharmaceuticals, Ltd
$24.31 from Pfizer Inc.
$23.24 from Medtronic MiniMed, Inc.
$21.43 from Dexcom, Inc.
$18.75 from DFINE, Inc
$16.66 from Auxilium Pharmaceuticals, Inc.
Payments received by Dr. Sarika Shivnani, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!